Difference between revisions of "Center for Medicine in the Public Interest"

From Powerbase
Jump to: navigation, search
(CMPI Advisory Board)
m (added astroturf category)
 
(41 intermediate revisions by 5 users not shown)
Line 1: Line 1:
 +
The '''Center for Medicine in the Public Interest''' (CMPI) claims to be a ‘nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered.’ It offers ‘the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness. <ref> CMPI. [http://www.cmpi.org/about-us/mission-statement/ CMPI: Mission Statement] Accessed 19 April 2010./</ref> The director of the [[Stockholm Network]] (SN), [[Helen Disney]], used to sit on its now defunct advisory board along with representatives from two think tanks involved in the Network: [[International Policy Network]] ([[Julian Morris]]) and [[Centre for the New Europe]] ([[Stephen Pollard]]).<ref>Centre for Medicine in the Public Interest, [http://web.archive.org/web/20060113193713/www.rxcmpi.org/board/index.html CMPI Advisory Board], Centre for Medicine in the Public Interest, 13-January-2006, Accessed vi web archive 25-May-2010</ref> The director of communications at [[Pfizer]] [[Catherine Barr Windels]] is also on the CPMI board.<ref>CPMI Board of Directors, [http://www.cmpi.org/about-us/board-of-directors/ About Us], ''Centre for Medicine in the Public Interest'', Accessed 24-May-2010</ref>
  
==CMPI Board of Directors==
+
The CPMI has been accused of being an 'astroturf' organisation that receives its funding from pharmaceutical companies.<ref>Peter Hart, Fear & Favor 2008; Financial woes accelerate corporate pressure in the newsroom, ''Extra!'', April 2009</ref><ref>Shannon Brownlee and Jeanne Lenzer, Doctor's Fees, ''Slate Magazine'', 21-November-2008</ref> According to the ''Washington Post'':
  
The CMPI Board of Directors is comprised of some of the nation’s leaders in academic medical research, clinical practice, health care delivery, patient advocacy, innovation leadership and science reporting. The board will be involved in helping CMPI reaching a broader group of stakeholders in their respective communities and in shaping CMPI programs in the future.
+
:The Center for Medicine in the Public Interest (CMPI) is a New York-based think tank headed by [[Peter Pitts]], a former Food and Drug Administration official who appears frequently on newscasts condemning Democratic health-care proposals. CMPI is an offshoot of the San Francisco-based [[Pacific Research Institute]], which has received foundation grants over the years from [[Philip Morris]], [[Pfizer]] and the [[Pharmaceutical Research and Manufacturers of America]], according to public records.
  
Bruce Booth
+
:While serving as president of CMPI, Pitts also works as the global health-care chief at [[Porter Novelli]], a New York public relations firm whose clients include [[Johnson & Johnson]], [[GlaxoSmithKline]], [[Wyeth]] and [[Pfizer]]. He acknowledges that CMPI also receives money from the pharmaceutical industry, which is supporting reform legislation in exchange for a White House promise to limit cuts.<ref>Dan Eggen, Funding for health-care interest groups often fuzzy, ''Washington Post'', 7-January-2010</ref>
 
  
Principal,
+
The CPMI was an offshoot of the [[Pacific Research Institute]] which Rachel Maddow describes as 'a famous pro-tobacco ostensibly grassroots corporate front group that was funded by [[Philip Morris]]'.<ref>Rachel Maddow, The Rachel Maddow Show, ''MSNBC'', 18-November-2009, 9PM EST</ref>
Atlas Venture
 
  
Bruce Brandfon
+
==Funding and disambiguation==
+
The Center for Medicine in the Public Interest should not to be confused with the [[Center for Science in the Public Interest]] (CSPI). The two are completely unrelated, despite their very similar sounding names. The CSPI is a non profit public interest group, while the CMPI takes corporate funding.
  
Publisher,
+
CSPI says it does not accept funding from corporations or government; instead it is funded by individual donors, foundation grants, and subscriptions to its newsletter.<ref>[http://www.cspinet.org/about/funding.html CSPI's Funding Sources], CSPI website, acc 21 Apr 2010</ref>
Scientific American
 
  
Fred Goodwin, M.D.
+
CMPI, on the other hand, stated on a 2005 version of its website that it accepted corporate funding:
+
:Its contributors consist primarily of foundations and individuals, with some corporate support, as described in its 2004 annual report.
  
Professor of Psychiatry,
+
:PRI solicits and accepts donations from corporations in the health care industry. In order to avoid conflicts of interest, PRI staff and external authors adhere to a Code of Practice.<ref>[http://web.archive.org/web/20060103045954/www.rxcmpi.org/about/index.html About Center for Medicines in the Public Interest], CMPI website, archived version copyrighted 2005, accessed in web archive 21 Apr 2010</ref>
The George Washington University Medical Center.
 
  
Dennis Johnson
+
CMPI has also been funded in part by the pharmaceutical industry. According to Politico.com, CMPI`s biggest contributors in 2006 were the drug maker [[Pfizer]] and [[PhRMA]], the drug industry`s trade group.<ref>Rachel Maddow, The Rachel Maddow Show, ''MSNBC'', 18-November-2009, 9PM EST</ref>
 
  
Vice President,
+
==US Health care reform debate==
Policy and External Affairs at The Children’s Health Fund
 
  
Suzanne Pattee, J.D.
+
CMPI was 'a big player' in the U.S. anti-health reform movement in late 2009. They sponsored anti-Obama tea party protests and organized a 'U.S. Policymakers' series that hosted anti-health reform interviews with a 'not-so-broad range of Republican lawmakers, including [[Michele Bachmann]], [[Joe Wilson]], [[Jim DeMint]], [[David Vitter]]'. They also produced 'a number of anti-health reform online ads and video and even anti-health reform video games'.<ref>Rachel Maddow, The Rachel Maddow Show, ''MSNBC'', 18-November-2009, 9PM EST</ref>
 
  
Vice president,
+
[[Porter Novelli]], the PR firm that employs [[Peter Pitts]] who heads CMPI, 'helped that industry kill the Patients Bill of Rights way back in 1994', arguing that it was part of a 'big government agenda', the same arguments used to dicredit the US Healthcare reforms in 2009.<ref>Rachel Maddow, The Rachel Maddow Show, ''MSNBC'', 18-November-2009, 9PM EST</ref>
Public Policy and Patient Affairs for the Cystic Fibrosis
 
  
Steven Sammut
+
==People==
+
===Board of Directors===
 +
*[[Gad Berdugo]], General Partner, Explorium Capital LLC
 +
*[[Fred Goodwin (psychiatrist)|Fred Goodwin]], M.D. Professor of Psychiatry, The George Washington University Medical Center.
 +
*[[Steven Sammut]], Lecturer, Wharton School, the Law School and the School of Engineering and Applied Science of the University of Pennsylvania
 +
*[[Mark Thornton]], M.D., Ph.D. Chairman and President, Sarcoma Foundation of America
 +
*[[Michael Weber]], M.D. Professor of Medicine SUNY Downstate College of Medicine, Brooklyn, New York
 +
*[[Catherine Barr Windels]], Principle, [[OnPoint Strategies, LLC]] (formerly of [[Pfizer]]<ref>CPMI Board of Directors, [http://www.cmpi.org/about-us/board-of-directors/ About Us], ''Centre for Medicine in the Public Interest'', Accessed 24-May-2010</ref>
  
Lecturer,
+
===Founders===
Wharton School, the Law School and the School of Engineering and Applied Science of the University of Pennsylvania
 
  
Mark Thornton, M.D., Ph.D.
+
*[[Peter J. Pitts]] – President of CMPI and Partner/Director of Global Healthcare at [[Porter Novelli]]
+
*[[Robert Goldberg]] - Vice President and Director of Programs at CMPI
  
Chairman and President,
+
===CMPI Advisory Board (no longer in existence)===
Sarcoma Foundation of America
+
Until at least 2006 the CMPI published an advisory board.<ref>CMPI [http://web.archive.org/web/20060113193713/www.rxcmpi.org/board/index.html CMPI Advisory board], retrieved from the Internet Archive of 13 January 2006, accessed 25 may 2010</ref>
 +
====January 2006====
 +
*[[Joesph L. Bast]] President and CEO, The [[Heartland Institute]], Chicago, IL | [[John E. Calfee]] Senior Fellow, [[American Enterprise Institute]], Washington, D.C. | [[Joseph A. DiMasi]], Ph.D. Director of Economic Analysis, [[Tufts Center for the Study of Drug Development]], Tufts University, Boston, MA | [[Helen Disney]] Director, [[Stockholm Network]], London, England | [[Robert Goldberg]] Senior Fellow Manhattan Institute | [[John R. Graham]] Director for Healthcare Studies Pacific Research Institute | [[John Kamp]] Executive Director, [[Coalition for Healthcare Communication]] | [[Sam Kazman]] General Counsel, [[Competitive Enterprise Institute]] | [[Thomas T. Kubic]] Executive Director [[Pharmaceutical Security Institute]] | Dr. [[Merrill Mathews, Jr.]] Resident Scholar, [[Institute for Policy Innovation]] Director, [[Council for Affordable Health Insurance]] | [[David McIntosh]] Attorney, [[Mayer, Brown, Rowe & Maw]] LLP, Washington, D.C. | [[Henry I. Miller]] Research Fellow [[Hoover Institution]] | [[Julian Morris]] Director, [[International Policy Network]], London | [[Sally C. Pipes]] President and CEO [[Pacific Research Institute]] | [[Peter J. Pitts]] Senior Fellow for Healthcare Studies [[Pacific Research Institute]] Senior Vice President for Health Affairs [[Manning, Selvage & Lee]] | [[Stephen Pollard]] Senior Fellow at the [[Centre for the New Europe]], Brussels, Belgium | [[William Roper]] CEO, University of North Carolina Health Care System | [[Ellen V. Sigal]], Ph.D. Founder and Chairperson, [[Friends of Cancer Research]] | [[Samuel C. Silverstein]], M.D. John C. Dalton Professor and Chairman, Department of Physiology and Cellular Biophysics, Columbia University Professor of Medicine, College of Physicians and Surgeons, Columbia University | [[Philip Stieg]], M.D. Professor and Chairman, Department of Neurological Surgery, Weill Medical College Neurosurgeon-in-Chief, New York-Presbyterian Hospital | [[Daniel E. Troy]] Former Chief Counsel of the [[Food and Drug Administration]] (FDA) Partner in the Washington, New York Offices of [[Sidley Austin Brown & Wood]] | [[Grace Marie Turner]] President, The [[Galen Institute]] | [[Ben Zycher]] Senior Fellow in Economics, [[Pacific Research Institute]] Adjunct scholar, [[Cato Institute]], [[Claremont Institute]]
  
Michael Weber, M.D.
+
====??====
+
*[[Joesph L. Bast]] President and CEO, The [[Heartland Institute]], Chicago, IL
 +
*[[John E. Calfee]] Senior Fellow, [[American Enterprise Institute]], Washington, D.C.
 +
*[[Joseph A. DiMasi]], Ph.D. Director of Economic Analysis, [[Tufts Center for the Study of Drug Development]], Tufts University, Boston, MA
 +
*[[Helen Disney]] Director, [[Stockholm Network]], London, England
 +
*[[John Kamp]] Executive Director, [[Coalition for Healthcare Communication]]
 +
*[[Sam Kazman]] General Counsel, [[Competitive Enterprise Institute]]
 +
*Dr. [[Merrill Mathews]], Jr. Resident Scholar, [[Institute for Policy Innovation]] Director, [[Council for Affordable Health Insurance]]
 +
*[[David McIntosh]] Attorney, [[Mayer, Brown, Rowe & Maw]] LLP, Washington, D.C.
 +
*[[Julian Morris]] Director, [[International Policy Network]], London
 +
*[[Tomas J. Philipson]] Professor, The Harris School, Chicago, IL
 +
*[[Stephen Pollard]] Senior Fellow at the [[Centre for the New Europe]], Brussels, Belgium
 +
*[[William Roper]] CEO, University of North Carolina Health Care System
 +
*[[Ellen V. Sigal]], Ph.D. Founder and Chairperson, [[Friends of Cancer Research]]
 +
*[[Samuel C. Silverstein]], M.D. John C. Dalton Professor and Chairman, Department of Physiology and Cellular Biophysics, Columbia University Professor of Medicine, College of Physicians and Surgeons, Columbia University
 +
*[[Philip Stieg]], M.D. Professor and Chairman, Department of Neurological Surgery, Weill Medical College Neurosurgeon-in-Chief, New York-Presbyterian Hospital
 +
*[[Daniel E. Troy]] Former Chief Counsel of the [[Food and Drug Administration]] (FDA) Partner in the Washington, New York Offices of [[Sidley Austin Brown & Wood]]
 +
*[[Grace Marie Turner]] President, The [[Galen Institute]]
 +
*[[Ben Zycher]] Senior Fellow in Economics, [[Pacific Research Institute]] Adjunct scholar, [[Cato Institute]], [[Claremont Institute]]
  
Associate Dean and Professor of Medicine
+
==Publications and Affiliations==
SUNY Downstate College of Medicine
 
Brooklyn, New York
 
  
Raymond Woosley, M.D., Ph.D.
+
*On 20 September 2005, the CMPI released a report called 21ST CENTURY HEALTH CARE TERRORISM: THE PERILS OF INTERNATIONAL DRUG COUNTERFEITING with the [[Pacific Institute]]. It was authored by [[Peter Pitts]], founder of CMPI, along with  [[Michael Tew]] and [[ Alexandra Preate]] from [[Capital HQ]]. <ref>[[Peter Pitts]], [[Michael Tew]] and [[ Alexandra Preate]]. 20 September 2005.  [http://cmpi.org/uploads/File/21st-Century-Terrorism.Report.pdf 21ST CENTURY HEALTH CARE TERRORISM: THE PERILS OF INTERNATIONAL DRUG COUNTERFEITING] Accessed 19 April 2010.</ref>
 
  
President and CEO,
+
==Contact ==
C-Path Institute.
 
  
==CMPI Advisory Board==
+
:Headquarters:
+
:Address:
 +
:308 East 38th Street
 +
:Suite 201
 +
:New York, New York 10016
 +
:Phone:(212) 417-9169
 +
:Fax: (212) 417-9170
 +
:email: info@cmpi.org
  
Joesph L. Bast
+
:Paris Office
President and CEO
+
:3 rue Primatice
The Heartland Institute
+
:75013 Paris
Chicago, IL
+
:Phone: + 33 1 43 31 89 25
 
 
  
John E. Calfee
 
Senior Fellow
 
American Enterprise Institute
 
Washington, D.C.
 
 
  
Joseph A. DiMasi, Ph.D.
 
Director of Economic Analysis
 
Tufts Center for the Study of Drug Development
 
Tufts University, Boston, MA
 
 
  
[[Helen Disney]]
 
Director
 
[[Stockholm Network]]
 
London, England
 
 
  
John Kamp
 
Executive Director
 
Coalition for Healthcare Communication
 
 
  
Sam Kazman
+
==Notes==
General Counsel
+
<references/>
Competitive Enterprise Institute
 
 
  
Dr. Merrill Mathews, Jr.
+
[[Category:Think Tanks]][[Category:Pharma]][[Category:Astroturf]]
Resident Scholar
 
Institute for Policy Innovation
 
Director
 
Council for Affordable Health Insurance
 
 
 
 
 
David McIntosh
 
Attorney
 
Mayer, Brown, Rowe & Maw LLP
 
Washington, DC.
 
 
 
 
 
[[Julian Morris]]
 
Director
 
[[International Policy Network]] (London)
 
 
 
 
Tomas J. Philipson
 
Professor
 
The Harris School
 
Chicago, IL
 
 
 
 
[[Stephen Pollard]]
 
Senior Fellow at the [[Centre for the New Europe]]
 
Brussels, Belgium
 
 
 
 
 
William Roper
 
CEO
 
University of North Carolina Health Care System
 
 
 
 
[[Ellen V. Sigal]], Ph.D.
 
Founder and Chairperson
 
[[Friends of Cancer Research]]
 
 
 
 
 
Sam Silverstein, M.D.
 
John C. Dalton Professor of Physiology
 
and Cellular Biophysic
 
Professor of Medicine
 
Columbia University
 
 
 
 
Philip Stieg, MD
 
Professor and Chairman
 
Department of Neurological Surgery
 
Weill Medical College
 
Neurosurgeon-in-Chief
 
New York-Presbyterian Hospital
 
 
 
 
Daniel E. Troy
 
Former Chief Counsel of the FDA
 
Partner in the Washington, New York Offices of
 
Sidley Austin Brown and Wood
 
 
 
 
 
[[Grace Marie Turner]]
 
President
 
The Galen Institute
 
 
 
 
[[Ben Zycher]]
 
Senior Fellow in Economics
 
[[Pacific Research Institute]]
 
Adjunct scholar
 
[[Cato Institute]], [[Claremont Institute]]
 

Latest revision as of 16:52, 14 December 2010

The Center for Medicine in the Public Interest (CMPI) claims to be a ‘nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered.’ It offers ‘the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness. [1] The director of the Stockholm Network (SN), Helen Disney, used to sit on its now defunct advisory board along with representatives from two think tanks involved in the Network: International Policy Network (Julian Morris) and Centre for the New Europe (Stephen Pollard).[2] The director of communications at Pfizer Catherine Barr Windels is also on the CPMI board.[3]

The CPMI has been accused of being an 'astroturf' organisation that receives its funding from pharmaceutical companies.[4][5] According to the Washington Post:

The Center for Medicine in the Public Interest (CMPI) is a New York-based think tank headed by Peter Pitts, a former Food and Drug Administration official who appears frequently on newscasts condemning Democratic health-care proposals. CMPI is an offshoot of the San Francisco-based Pacific Research Institute, which has received foundation grants over the years from Philip Morris, Pfizer and the Pharmaceutical Research and Manufacturers of America, according to public records.
While serving as president of CMPI, Pitts also works as the global health-care chief at Porter Novelli, a New York public relations firm whose clients include Johnson & Johnson, GlaxoSmithKline, Wyeth and Pfizer. He acknowledges that CMPI also receives money from the pharmaceutical industry, which is supporting reform legislation in exchange for a White House promise to limit cuts.[6]

The CPMI was an offshoot of the Pacific Research Institute which Rachel Maddow describes as 'a famous pro-tobacco ostensibly grassroots corporate front group that was funded by Philip Morris'.[7]

Funding and disambiguation

The Center for Medicine in the Public Interest should not to be confused with the Center for Science in the Public Interest (CSPI). The two are completely unrelated, despite their very similar sounding names. The CSPI is a non profit public interest group, while the CMPI takes corporate funding.

CSPI says it does not accept funding from corporations or government; instead it is funded by individual donors, foundation grants, and subscriptions to its newsletter.[8]

CMPI, on the other hand, stated on a 2005 version of its website that it accepted corporate funding:

Its contributors consist primarily of foundations and individuals, with some corporate support, as described in its 2004 annual report.
PRI solicits and accepts donations from corporations in the health care industry. In order to avoid conflicts of interest, PRI staff and external authors adhere to a Code of Practice.[9]

CMPI has also been funded in part by the pharmaceutical industry. According to Politico.com, CMPI`s biggest contributors in 2006 were the drug maker Pfizer and PhRMA, the drug industry`s trade group.[10]

US Health care reform debate

CMPI was 'a big player' in the U.S. anti-health reform movement in late 2009. They sponsored anti-Obama tea party protests and organized a 'U.S. Policymakers' series that hosted anti-health reform interviews with a 'not-so-broad range of Republican lawmakers, including Michele Bachmann, Joe Wilson, Jim DeMint, David Vitter'. They also produced 'a number of anti-health reform online ads and video and even anti-health reform video games'.[11]

Porter Novelli, the PR firm that employs Peter Pitts who heads CMPI, 'helped that industry kill the Patients Bill of Rights way back in 1994', arguing that it was part of a 'big government agenda', the same arguments used to dicredit the US Healthcare reforms in 2009.[12]

People

Board of Directors

Founders

CMPI Advisory Board (no longer in existence)

Until at least 2006 the CMPI published an advisory board.[14]

January 2006

??

Publications and Affiliations

Contact

Headquarters:
Address:
308 East 38th Street
Suite 201
New York, New York 10016
Phone:(212) 417-9169
Fax: (212) 417-9170
email: info@cmpi.org
Paris Office
3 rue Primatice
75013 Paris
Phone: + 33 1 43 31 89 25



Notes

  1. CMPI. CMPI: Mission Statement Accessed 19 April 2010./
  2. Centre for Medicine in the Public Interest, CMPI Advisory Board, Centre for Medicine in the Public Interest, 13-January-2006, Accessed vi web archive 25-May-2010
  3. CPMI Board of Directors, About Us, Centre for Medicine in the Public Interest, Accessed 24-May-2010
  4. Peter Hart, Fear & Favor 2008; Financial woes accelerate corporate pressure in the newsroom, Extra!, April 2009
  5. Shannon Brownlee and Jeanne Lenzer, Doctor's Fees, Slate Magazine, 21-November-2008
  6. Dan Eggen, Funding for health-care interest groups often fuzzy, Washington Post, 7-January-2010
  7. Rachel Maddow, The Rachel Maddow Show, MSNBC, 18-November-2009, 9PM EST
  8. CSPI's Funding Sources, CSPI website, acc 21 Apr 2010
  9. About Center for Medicines in the Public Interest, CMPI website, archived version copyrighted 2005, accessed in web archive 21 Apr 2010
  10. Rachel Maddow, The Rachel Maddow Show, MSNBC, 18-November-2009, 9PM EST
  11. Rachel Maddow, The Rachel Maddow Show, MSNBC, 18-November-2009, 9PM EST
  12. Rachel Maddow, The Rachel Maddow Show, MSNBC, 18-November-2009, 9PM EST
  13. CPMI Board of Directors, About Us, Centre for Medicine in the Public Interest, Accessed 24-May-2010
  14. CMPI CMPI Advisory board, retrieved from the Internet Archive of 13 January 2006, accessed 25 may 2010
  15. Peter Pitts, Michael Tew and Alexandra Preate. 20 September 2005. 21ST CENTURY HEALTH CARE TERRORISM: THE PERILS OF INTERNATIONAL DRUG COUNTERFEITING Accessed 19 April 2010.